Disregard Everything I Say

Dosage (oral)
Threshold : 3 - 5 mg
Light : 10 - 20 mg
Common : 15 - 30 mg
Strong : 10 - 50 mg
Heavy : 25 - 60mg

Duration (oral)
Total duration : 5 - 10 hrs
Onset  : 60 - 90 mins
Come up : 15 - 30 minutes
Peak : 3 - 7 hours
Come down : 1 - 2 hours
After effects : 2 - 4 hours
Dosage (insufflated)
Threshold : 1 - 3 mg
Light : 2 - 10 mg
Common : 5 - 15 mg
Strong : 5 - 20 mg
Heavy : 7 - 25 + mg
Duration (insufflated)
Total duration : 3 - 7 hours
Onset : 5 - 15 mins
Come up : 20 - 60 mins
Peak : 2 - 4 hours
Come down : 1 - 2 hours
After effects : 1 - 2 + hours
2C-T-7 (2,5-dimethoxy-4-propylthiophenethylamine) is a psychedelic phenethylamine of the 2C-x family. It was first synthesized by Alexander Shulgin in his book PiHKAL: A Chemical Love Story. This particular substance is part of the so-called “magical half-dozen” list which refers to Shulgin’s self-rated most important phenethylamine compounds, all of which except mescaline he developed and synthesized himself. They are found within the first book of PIHKAL, and are as follows: Mescaline, DOM, 2C-B, 2C-E, 2C-T-2 and 2C-T-7.

In terms of its chemistry, 2C-T-7 is a substituted phenethylamine with methoxy groups attached to carbons R2 and R5as well as a sulfide chain attached to carbon R4.

In terms of its pharmacology, 2C-T-7 has efficacy at the 5-HT2A receptor as a partial agonist. This is a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines. Along side of this, as the 2,5-desmethoxy derivative of 2C-T-7 has been shown to be a moderate monoamine oxidase A inhibitor, this substance may likewise have MAOI effects.

2C-T-7 is a highly dose sensitive psychedelic known for its strong visuals and intense body load. Many reports also indicate that the effects of this chemical may be overly intense for those who are not already experienced with psychedelics. The experience contains a complex and wide array of effects which based on the predefined potential subjective effects index found here, I will now begin to breakdown and describe.

Physical effects:

The physical effects of 2C-T-7 can be broken down into six components all of which progressively intensify proportional to dosage. These are described below and generally include:

• Spontaneous tactile sensations - The body high of 2C-T-7 is intense but, in comparison to 2C-E or 2C-B, it can be considered mild though is still capable of becoming very powerful and highly physically euphoric. It is similar yet distinct from the body high experienced on 2C-E, 2C-B, and LSD. The sensation itself can be described as intense and will manifest itself in the form of a continuously shifting tingling sensation that travels up and down the body in spontaneous waves.
• Stimulation - In terms of its effects on the physical energy levels of the tripper 2C-T-7 is usually considered to be very energetic and stimulating in a fashion that is quite comparable to that of other phenethylamines such as 2C-B, 2C-E and 2C-P.
• Increased bodily control - Although this component is capable of manifesting itself in a distinct and noticeable fashion for most users it does not generally seem to be as apparent or intense as the same component found within LSD and 2C-B.
• Enhancement of touch
• Nausea - Mild to extreme nausea is commonly reported when consumed in moderate to high dosages and either passes once the tripper has vomited or gradually fades by itself as the peak sets in.
• Loss of temperature regulation

Cognitive effects:

The head space of 2C-T-7 is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high dosages.

The total sum of these cognitive components regardless of the setting generally includes:

• Enhancement of current mind state
• Acceleration of thought
• Feelings of fascination, importance and awe
• Time distortion
• Introspection
• Outrospection
• Removal of cultural filter
• Conceptual thinking
• Ego suppression, loss and death
• Thought loops
• Feelings of interdependent opposites
• Delusions
• States of unity and interconnectedness

Visual effects:

Enhancements

2C-T-7 presents a full and complete array of possible visual enhancements which generally includes:

• Increased visual acuity
• Enhancement of colour
• Enhanced pattern recognition

Distortions

2C-T-7 presents a full and complete array of possible visual distortions which generally includes:

• Drifting (Melting, Flowing, Breathing and morphing) - In comparison to other psychedelics, this effect can be described as highly detailed, slow and smooth in motion, static in their appearance and extremely realistic in style but with a subtle digital/cartoonish form.
• Tracers
• After images
• Texture repetition
• Colour shifting
• Scenery slicing

Geometry

The visual geometry that is present throughout this trip can be described as more similar in appearance to that of 4-AcO-DMT or Ayahuasca than that of LSD, 2C-B or 2C-I. They can be comprehensively described as structured in their organization, organic in geometric style, intricate in complexity, large in size, fast and smooth in motion, colourful in scheme, glossy in colour, sharp in their edges and equally rounded and angular in their corners. They give off a contradictory natural and synthetic feel with slightly more mystical and shamanic undertones to them in comparison to other phenethylamines. At higher dosages they are equally likely to result in states of Level 7A visual geometry and Level 7B. There seems to be visual geometry that is extremely similar to 2C-E and 2C-P and can be described as equal in intensity or complexity and equal in proportion to the accompanying cognitive and physical effects.

Hallucinatory states

2C-T-7 produces a full range of high level hallucinatory states in a fashion that is more consistent and reproducible than that of many other commonly used psychedelics. This holds particularly true in comparison to other substances within the phenethylamine family. These effects include:

• External hallucinations
• Internal hallucinations - In comparison to other psychedelics such as LSD, 2C-T-7 is very high in hallucinations embedded within visual geometry. This particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

Auditory effects

The auditory effects of 2C-T-7 are more common in their occurrence than many more commonly used psychedelics and exhibit a full range of effects which commonly includes:

• Enhancements
• Distortions
• Hallucinations

Health effects, addiction potential and tolerance:

The toxicity and long term health effects of recreational 2C-T-7 use does not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because 2C-T-7 is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried 2C-T-7 within the psychedelic community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly (but nothing can be completely guaranteed).

2C-T-7 does not seem to be physically addictive and many users experience a self regulating quality. There seems to be a tolerance build up when used consecutively multiple days in a row which requires one to double their dosage each time to achieve the same effects.

There is no current data for the LD50 of 2C-T-7, but it is thought to be high. Erowid does however have some annecdotal information on fatal dosages occurring at 35mg+ of insufflated dosages.

If 2C-T-7 does have MAOI effects, this could indicate that 2C-T-7 is more likely to induce serotonin syndrome, especially at high dosages, than other serotonergic hallucinogens. This may make it dangerous to combine with certain substances such as MDMA, AMT, Ayahuasca or any substance which releases neurotransmitters such as serotonin or those with similar pharmocological effects.

Legal issues:

• 2C-T-7 is scheduled in Germany.
• In Australia, 2C-T-2 and 2C-T-7 are covered by the country’s analogue drug laws.
• 2C-T-7 is unscheduled in Canada.
• The Netherlands was the first country in the world to ban 2C-T-7, after being sold in smartshops for a short period. After 2C-T-2 was first banned, 2C-T-7 quickly appeared on the market, but was soon banned as well. 2C-T-7 is a list I drug of the Opium Law.
• Schedule I in Sweden. 2C-T-7 was first classified as “health hazard” under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of April 1, 1999 under SFS 1999:58 that made it illegal to sell or possess.
• In 1999, Alexander Shulgin was sent a copy of a letter from the British Home Office to several of its administrative associates that in effect placed all compounds listed in PiHKAL into Class A.
• On September 20, 2002, 2C-T-7 was classified as a Schedule I substance in the United States by an emergency ruling by the DEA. On March 18, 2004, the DEA published a Final Rule in the Federal Register permanently placing 2C-T-7 in Schedule I.

Conclusion:

2C-T-7 shows incredible depth on both an insightful and a recreational level with a full spectrum of deep psychedelic effects. It is completely worthy of its position within the magical half dozen and an extremely versatile compound. I would recommend this experience to anybody willing to try it in a safe and sensible manner.

This substance breakdown was written in collaboration with PsychonautWiki admin PJosepherum. For a more detailed breakdown please click the here.

Dosage:

Threshold : 0.2 mg
Light : 0.2 - 0.75 mg
Common : 0.75 - 1.75 mg
Strong : 1.75 - 2.5 mg
Heavy : 2.5 - 3.5 mg+

Duration:

Total duration : 7 - 17 hours
Onset / Initial effects : 30 - 90 mins
Coming up : 60 - 90 mins
Peak : 3 - 8 hrs
Coming down : 3 - 8 hrs
After effects : 4 - 8 hrs

Dimethoxybromoamphetamine (DOB), also known as Brolamfetamine and Bromo-DMA, is a psychedelic substituted alpha-methylated phenethylamine, a class of compounds commonly known as amphetamines. The phenethylamine equivalent of this substance (lacking the alpha-methyl group) is 2C-B.

This substance has no history of human usage prior to the 1991 publication of its synthesis and pharmacology in the book PiHKAL (Phenethylamines i Have Known And Loved) by Alexander Shulgin. In modern times it is used as a recreational drug and an entheogen, rarely sold on the streets and almost exclusively obtained as a grey area research chemical through the use of online vendors. It was first synthesized by Alexander Shulgin and described in his 1991 book.

In terms of its pharmacology, this substance acts as a selective 5-HT2A, 5-HT2B, and 5-HT2C receptor partial agonist. Its psychedelic effects are thought to be mediated via its actions on the 5-HT2A receptor.

The DOB experience contains a complex and wide array of effects which based on the predefined potential subjective effects index found here, I will now begin to breakdown and describe.

Physical effects:

The physical effects of DOB can be broken down into six components all of which progressively intensify proportional to dosage. These are described below and generally include:

• Spontaneous tactile sensations - The body high of DOB is manifested as somewhat intense in comparison to most classical psychedelics. The sensation itself can be described as a constantly present yet somewhat mild energetic pins and needles sensation that encompasses a person’s entire body. It is usually static in its position and felt over every square inch of the skin as if it was coming from behind the users body. Occasionally however it manifests itself in the form of a continuously shifting tingling sensation that travels up and down the body in spontaneous waves.
• Stimulation - In terms of its effects on the physical energy levels of the tripper, DOB is usually considered to be extremely stimulating at levels which do not become overwhelming and are encouraged instead of forced. This results in a shakiness and unsteadiness of the hands at high dosages but encourages trippers to move around, run, dance, climb and generally engage in physical activities. The level of stimulation varies between users however with some people reporting it to be somewhat similar to amphetamine in its intensity and others reporting that it is extremely subtle even at higher dosages. In comparison, other more commonly used psychedelics such as psilocin are generally sedating and relaxed.
• Enhancement of touch - Feelings of enhanced tactile sensation are consistently present at moderate levels throughout most DOB trips.
• Nausea - Mild to extreme nausea is reported when consumed in moderate to high dosages and either passes once the tripper has vomited or gradually fades by itself as the peak sets in.
• Vasoconstriction - This effect is usually only present at higher dosages but can be particularly uncomfortable.

Cognitive effects:

The head space of DOB is described by many as one of mental stimulation and a powerful enhancement of a person’s current mental state. Many user report that it may not be as deep as other traditional psychedelics such as LSD or Psilocin and that it is comparatively empty in terms of its insightfulness.

The total sum of these cognitive components regardless of the setting generally includes:

• Introspection - This component is consistently manifested only in the context of a non-social setting in which the user is alone.
• Increased empathy, love and sociability - This component is inconsistently manifested only in the context of social settings in which one is within the company of others. These feelings of sociability, love and empathy are a little weaker and less sharp than those found on substances such as MDMA and 2C-B but still prove strong enough to provide long lasting therapeutic effects.
• Acceleration of thought
• Time distortion
• Feelings of fascination, importance and awe
• Conceptual thinking
• Enhancement of current mind state
• Ego suppression, loss and death

Visual effects:

Enhancements

DOB presents a full and complete array of possible visual enhancements which generally includes:

• Increased visual acuity
• Enhancement of colour
• Enhanced pattern recognition

Distortions

DOB presents a full and complete array of possible visual distortions which generally includes:

• Drifting (Melting, Flowing, Breathing and morphing) - In comparison to other psychedelics, this effect can be described as highly detailed, slow and smooth in motion, static in their appearance and unrealistic/cartoon-like in style.
• Tracers
• After images
• Texture repetition
• Colour shifting
• Scenery slicing

Geometry

The visual geometry that is present throughout this trip can be described as more similar in appearance to that of LSD, 25I-NBOME or 2C-B than that of Ayahuasca, Psilocin or 2C-E. They can be comprehensively described as unstructured in their organization, algorithmic in geometric style, intricate in complexity, small in size, fast and smooth in motion, colourful in scheme, glossy in colour, sharp in their edges and equally rounded and angular in their corners. They give off a synthetic feel to them that at higher dosages are significantly more likely to result in states of Level 7A visual geometry over Level 7B.

Hallucinatory states

DOB is capable of producing a full range of low and high level hallucinatory states in a fashion that is significantly less consistent and reproducible than that of many other commonly used psychedelics. These effects include:

• External hallucinations
• Internal hallucinations - Although DOB is technically capable of producing of hallucinatory states in a fashion that is on par with psilocin or DMT in its vividness and intensity, in comparison, these effects are extremely rare and inconsistent. Whilst traditional psychedelics such as LSA, Ayahuasca and Mescaline will induce internal hallucinations near consistently at level 5 geometry and above, DOB will for most simply go straight into Level 7A visual geometry. This lack of consistently induced hallucinatory breakthroughs means that for most, LSD is simply not as deep of an experience as certain other psychedelics.

Auditory effects:

The auditory effects of DOB are common in their occurrence and exhibit a full range of effects which commonly includes:

• Enhancements
• Distortions
• Hallucinations

Health effects, addiction potential and tolerance:

The toxicity and long term health effects of recreational DOB use do not seem to have been studied in any scientific context and the exact toxic dosage is unknown. This is because DOB is a research chemical with very little history of human usage. Anecdotal evidence from people who have tried DOC within the psychedelic community suggests that there are no negative health effects attributed to simply trying this drug at low to moderate doses or using it very sparingly but nothing can be completely guaranteed.

DOB is not physically addictive and many users experience a frequency self-regulating quality to the drug. Tolerance for DOC seems to be very mild and does not build up without repeated use over a short period of time.

Legal Issues:

• International: DOB is a Schedule I drug under the Convention on Psychotropic Substances.
• Australia: DOB is schedule II
• Canada: Listed as a Schedule 1 as it is an analogue of amphetamine.
• New Zealand: DOB is Schedule I (Class A) in New Zealand. DOB would also qualify as an “Analogue” under New Zealand’s catch-all Analogues section in Schedule 3 / Class C of their drug laws that would make 2C-I, 2C-E, DOI, DOB, ephedrine, and pseudoephedrine Schedule 3 compounds in New Zealand.
• Poland: DOB is controlled in Poland.
• UK: DOB is Schedule I/Class A in the U.K., making it illegal to sell, buy, or possess without a license.

Conclusion:

Although DOB could be considered as bland and generic in comparison to DOC and other more traditional psychedelics, it is still a worthwhile experience and perfect for recreational events. This substance can be generally described as a less insightful version of LSD with a longer duration, generic visual and an emptier headspace.

Click here for a more comprehensive breakdown.

Dosage:

Threshold : 100 µg
Light : 100 - 300 µg
Common : 350 - 700 µg
Strong : 700 - 1500 µg

Duration:

Total duration : 8 - 10 hrs
Onset / Initial effects : 15 - 60 mins
Coming up : 60 - 120 mins
Peak : 3 - 4 hrs
Coming down : 1 - 2 hrs
After effects : 5 - 24 hrs

25B-NBOMe can be fatal at heavy doses.^[1] It is strongly discouraged to take large amounts of this substance or to snort it.

25B-NBOMe or 2C-B-NBOMe is a serotonergic N-benzyl derivative of the substituted phenethylamine psychedelic known as 2C-B.

It has nearly no history of human use prior to 2010 when it first became popular due its ease of purchase from online research chemical vendors.

25B-NBOMe has efficacy at the 5-HT_2A receptor where it acts as a potent partial agonist. It was discovered in 2003 by Ralf Heim at the Free University of Berlin, it differs from 2C-B structurally through a substitution on the amine (NH2) with a 2-methoxybenzyl (BOMe) group as shown in the image above. This change in structure results in roughly a sixteen fold increase in potency when compared to 2C-B, allowing even the most extreme of dosages to fit in liquid form onto tabs and blotter paper (which people often mistake for LSD).

There are, however, methods of differentiating between LSD and adulterants like 25B-NBOMe with and without test kits.

For example, one of the key differences between 25B-NBOMe and LSD is that this substance is only active when taken through a sublingual or insufflated route. This means that in order to get the full effects, 25B-NBOMe blotter paper must be lightly chewed on within the mouth for 10 - 20 minutes and never immediately swallowed.

Insufflation, however, is not recommended due to the amount of people who have suffered through dangerous and often fatal overdoses due to this route of administration.

The 25B-NBOMe experience contains a complex and wide array of effects which based on the predefined potential subjective effects index found here, I will now begin to breakdown and describe.

Physical effects:

The physical effects of 25B-NBOMe can be broken down into six components all of which progressively intensify proportional to dosage. These are described below and generally include:

• Sublingual numbing - assuming the substance has been taken sublingually, the very first physical effect which a person will notice immediately after sublingual absorption is a strong, unpleasant metallic chemical taste. This is accompanied by a very obvious feeling of general numbness of the tongue and mouth which can stay for up to an hour after the blotter paper has been consumed. This is the key difference when it comes to determining whether your blotter paper contains LSD or one of the NBOMe series.
• Spontaneous tactile sensations - the body high itself can be described as a generally mild, all-encompassing, soft but euphoric tingling sensation. This tingling sensation is also accompanied by spontaneous rushes of euphoria that become longer and more drawn out proportional to the dosage consumed.
• Decreased bodily weight - in terms of the body’s perceived weight, this substance consistently leaves people feeling extremely light, often to the point of total weightlessness.
• Stimulation - in terms of its effects on the physical energy levels of the tripper, 25B-NBOMe is usually considered to be energetic and stimulating, but it can be considered less stimulating when compared to 25I-NBOMe. For most people, this substance induces a unique type of physical stimulation which can be described as feeling extremely energetic but in a way which does not force the tripper to move unless they genuinely choose to do so. For others however, the stimulation can be quite uncontrollable, occasionally resulting in bodily shakes and a grinding of the teeth comparable to that of MDMA and traditional stimulants such as amphetamine, but this is manifested much less consistently when compared to 25I-NBOMe
• Vasoconstriction - it is worth noting that an undetermined percentage of people who experiment with this drug will experience negative physical side effects, such as a temporary difficulty in urinating and vasoconstriction. This is defined as the narrowing of the blood vessels resulting from contraction of the muscular wall of the vessels and is triggered through the way in which 25B-NBOMe’s target receptor (5-HT2A) modulates both vasoconstriction and vasodilation among its many other functions.
• Nausea - as the tripper begins to come up, nausea is not uncommon and can sometimes result in initial vomiting, but passes once this has either happened or the trip begins to fully set in. In comparison to other psychedelics such as psilocin, LSD, 2C-E and 2C-I, this could actually be very considered very mild in its intensity.

Cognitive effects:

The head space of 25B-NBOMe is described by many as remarkably light and underwhelming in comparison to the classical psychedelics. It is not uncommon for people to report feeling that their thought stream has maintained general normality in its specific style throughout low to moderate dosages. At high dosages however, mild to overwhelming cognitive alterations become present.

The most prominent of these cognitive effects generally include:

• Introspection - this component is consistently manifested only in the context of a non-social setting in which the user is alone.
• Increased empathy, love and sociability - the entactogenic effects range from mild to powerful, but are inconsistently manifested. entactogenic effects for people who try this substance usually become prominent in the presence of others. These feelings of increased sociability, love and empathy do not seem to be quite as strong or profound as those found within other entactogens (such as MDMA, 2C-B and AMT)
• Acceleration of thought
• Time distortion
• Feelings of fascination, importance and awe
• Conceptual thinking
• Connectivity of thought
• Enhancement of current mind state
• Removal of cultural filter
• Ego suppression, loss and death

Visual effects:

Enhancements

25B-NBOMe presents a full and complete array of possible visual enhancements which generally includes:

• Increased visual acuity
• Enhancement of colour
• Enhanced pattern recognition

Distortions

The visual distortions and alterations which are experienced are detailed below:

• Drifting (Melting, Flowing, Breathing and morphing) - In comparison to other psychedelics, this effect can be described as highly detailed, slow and smooth in motion, static in their appearance and unrealistic/cartoon-like in style.
• Tracers
• After images
• Texture repetition
• Colour shifting
• Scenery slicing

Geometry

The visual geometry that is present throughout this trip is often described as similar in appearance to that of LSD. They can be comprehensively described as algorithmic in geometric style, intricate in complexity, fine and zoomed out in detail, fast and smooth in motion, structured in shape, colourful in scheme, glossy in colour, sharp around the edges and mostly rounded across their corners. In comparison to other more commonly used psychedelics they can be described as significantly more intricate than the visual geometry found within 2C-I and most of the 2C-x family in general as well as completely on par with LSD, Psilocin and DMT at appropriately high dosages.

In terms of their behaviour, 25B-NBOMe’s geometry leads onto Level 7A visual geometry with Level 7B remaining so far unconfirmed within this substance. They also seem to consistently build up in visual intensity when the tripper stares at a central point. This eventually envelops the visual field and creates the sensation that the tripper has broken through into a continuously shifting geometric landscape or structure with a vast sense of immersive physical size attributed to it.

Hallucinatory states

25B-NBOMe is capable of producing a full range of hallucinatory states within the level 1 - 3 range extremely consistently. However, level 4 hallucinatory breakthroughs are reported but very uncommon and inconsistent in comparison to other more commonly used psychedelics such as psilocin, 2C-E and DMT.

These effects include:

• External hallucinations
• Internal hallucinations - this particular effect commonly contains hallucinations with scenarios, settings, concepts and autonomous entity contact. They are more common within dark environments and can be described as internal in their manifestation, lucid in believability, interactive in style and almost exclusively of religious, spiritual, mystical or a transcendental nature in their overall theme.

Auditory effects:

The auditory effects of 25B-NBOMe are common in their occurrence and exhibit a full range of effects which commonly includes:

• Enhancements
• Distortions
• Hallucinations

Health effects, addiction potential and tolerance:

25B-NBOMe is a very new substance and little is known about its pharmacological or behavioural risks. The LD50 is not known. Some deaths have been attributed to 25B-NBOMe overdose caused by improper handling and uneducated use of this substance. Its recent widespread use suggests that death is primarily caused from overdoses and not from ordinary doses, particularly from insufflation.

The fact that 25B-NBOMe is active in the microgram range is likely a contributing factor since this makes measuring doses significantly more difficult. 

In terms of its addictive potential, 25B-NBOMe has not been studied formally but due to its immediate tolerance build up which lasts up to 2 - 3 weeks after the experience, it is essentially impossible to use this substance compulsively.

Legal issues:

• UK: 25B-NBOMe is under a temporary class drug order, lasting one year from 10th June 2013.
• Sweden: 25b-NBOMe is classed as schedule I.
• USA: On Nov 15, 2013, the DEA added 25B-NBOMe to Schedule I using their emergency scheduling powers, making it “temporarily” in Schedule I for 2 years.

Conclusion:

As for the substance itself, 25B-NBOMe  and the NBOMe series as a whole are an extremely interesting set of psychedelics but do not quite compare in terms of hallucinatory and cognitive depth if you have access to classical psychedelics such as genuine LSD, DMT and psilocin.

Please let me know if you agree or disagree with any particular points contained within this article by using the comment system below.

Click here for a more comprehensive article.

It may seem that I have been inactive recently due to a general lack of new original posts but I and others have been working extremely hard on overhauling and expanding upon the content within both DEIS and PsychonautWiki. This post is essentially a list of specific updates to inform my readers on the progress, changes and future of this website which can be found below:

• Psychedelics (Visual/Cognitive/Miscellaneous), Deliriants and Dissociative breakdowns have each received grammatical and descriptive overhauls.
• New previously undocumented psychedelic cognitive components added: Outrospection, Mindfulness, Multiple thought streams, Personality regression, Thought loops, Feelings of interdependent opposites and Delusions.
• New previously undocumented dissociative components: Environmental Cubism, Environmental Orbism.
• Hallucinatory states split into External and Internal hallucination categories for all hallucinogen breakdowns.
• Documentation article removed and stylistic variations of individual components (Geometry, Drifting, Spontaneous tactile sensations, etc) have simply been integrated into pre-existing articles for hallucinogen category breakdowns.
• All specific substance breakdowns have been updated to follow a consistent and standardized layout. This no longer describes each effect unless it contains a specific style or variation and instead asks one to refer back to our centralized potential subjective effects index for a detailed explanation.
• Responsible use page overhauled to be more comprehensive and legitimate.
• Non hallucinogenic substance categories added to PsychonautWiki with many more to come: Entactogens, Stimulants, Depressants, Nootropics, Opioids, Benzodiazapines.
• Non hallucinogenic breakdowns added to PsychonautWiki with many more to come: Amphetamine, Methylphenidate, Heroin, Codeine, Tramadol, Modafanil, Alprazolam and Cannabis.
• We now have an extremely active and dedicated community which is constantly progressing www.PsychonautWiki.org as we approach the release of V1.0. We are always looking for contributors and encourage you to visit our active IRC chatroom to talk with myself and other admins.
• Adverts have been implemented on DEIS. Sorry about this. You are welcome to hide them with AdBlock and an explanation of why this has been done can be found here.

As for the future, we are currently in the process of working on a full release for PsychonautWiki and have ten or so individual psychedelic substance breakdowns to post over up the upcoming weeks.

Thanks for reading and have a nice day <3